BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21118930)

  • 1. Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model.
    Chen CI; Clark DC; Pesavento P; Lerche NW; Luciw PA; Reisen WK; Brault AC
    Am J Trop Med Hyg; 2010 Dec; 83(6):1249-58. PubMed ID: 21118930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mayaro virus pathogenesis and immunity in rhesus macaques.
    Weber WC; Labriola CS; Kreklywich CN; Ray K; Haese NN; Andoh TF; Denton M; Medica S; Streblow MM; Smith PP; Mizuno N; Frias N; Fisher MB; Barber-Axthelm AM; Chun K; Uttke S; Whitcomb D; DeFilippis V; Rakshe S; Fei SS; Axthelm MK; Smedley JV; Streblow DN
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011742. PubMed ID: 37983245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates.
    Volk SM; Chen R; Tsetsarkin KA; Adams AP; Garcia TI; Sall AA; Nasar F; Schuh AJ; Holmes EC; Higgs S; Maharaj PD; Brault AC; Weaver SC
    J Virol; 2010 Jul; 84(13):6497-504. PubMed ID: 20410280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Sides of a Coin: a Zika Virus Mutation Selected in Pregnant Rhesus Macaques Promotes Fetal Infection in Mice but at a Cost of Reduced Fitness in Nonpregnant Macaques and Diminished Transmissibility by Vectors.
    Lemos D; Stuart JB; Louie W; Singapuri A; Ramírez AL; Watanabe J; Usachenko J; Keesler RI; Sanchez-San Martin C; Li T; Martyn C; Oliveira G; Saraf S; Grubaugh ND; Andersen KG; Thissen J; Allen J; Borucki M; Tsetsarkin KA; Pletnev AG; Chiu CY; Van Rompay KKA; Coffey LL
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody kinetics in infants exposed to Chikungunya virus infection during pregnancy reveals absence of congenital infection.
    Ramful D; Sampériz S; Fritel X; Michault A; Jaffar-Bandjee MC; Rollot O; Boumahni B; Gérardin P
    J Infect Dis; 2014 Jun; 209(11):1726-30. PubMed ID: 24338351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.
    Broeckel R; Fox JM; Haese N; Kreklywich CN; Sukulpovi-Petty S; Legasse A; Smith PP; Denton M; Corvey C; Krishnan S; Colgin LMA; Ducore RM; Lewis AD; Axthelm MK; Mandron M; Cortez P; Rothblatt J; Rao E; Focken I; Carter K; Sapparapau G; Crowe JE; Diamond MS; Streblow DN
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005637. PubMed ID: 28628616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia.
    Li FS; Carpentier KS; Hawman DW; Lucas CJ; Ander SE; Feldmann H; Morrison TE
    Cell Rep; 2023 May; 42(5):112418. PubMed ID: 37083332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale outbreak of Chikungunya virus infection in Thailand, 2018-2019.
    Khongwichit S; Chansaenroj J; Thongmee T; Benjamanukul S; Wanlapakorn N; Chirathaworn C; Poovorawan Y
    PLoS One; 2021; 16(3):e0247314. PubMed ID: 33690657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital and perinatal complications of chikungunya fever: a Latin American experience.
    Torres JR; Falleiros-Arlant LH; Dueñas L; Pleitez-Navarrete J; Salgado DM; Castillo JB
    Int J Infect Dis; 2016 Oct; 51():85-88. PubMed ID: 27619845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates.
    Rossi SL; Comer JE; Wang E; Azar SR; Lawrence WS; Plante JA; Ramsauer K; Schrauf S; Weaver SC
    J Infect Dis; 2019 Jul; 220(5):735-742. PubMed ID: 31053842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.
    Mallilankaraman K; Shedlock DJ; Bao H; Kawalekar OU; Fagone P; Ramanathan AA; Ferraro B; Stabenow J; Vijayachari P; Sundaram SG; Muruganandam N; Sarangan G; Srikanth P; Khan AS; Lewis MG; Kim JJ; Sardesai NY; Muthumani K; Weiner DB
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e928. PubMed ID: 21264351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular characterization of chikungunya virus in South Thailand.
    Theamboonlers A; Rianthavorn P; Praianantathavorn K; Wuttirattanakowit N; Poovorawan Y
    Jpn J Infect Dis; 2009 Jul; 62(4):303-5. PubMed ID: 19628911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chikungunya Virus Strains Show Lineage-Specific Variations in Virulence and Cross-Protective Ability in Murine and Nonhuman Primate Models.
    Langsjoen RM; Haller SL; Roy CJ; Vinet-Oliphant H; Bergren NA; Erasmus JH; Livengood JA; Powell TD; Weaver SC; Rossi SL
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes.
    Goo L; Dowd KA; Lin TY; Mascola JR; Graham BS; Ledgerwood JE; Pierson TC
    J Infect Dis; 2016 Nov; 214(10):1487-1491. PubMed ID: 27655868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chikungunya virus infection in children from India during 2009-2010: A cross sectional observational study.
    Raghavendhar BS; Ray P; Ratagiri VH; Sharma BS; Kabra SK; Lodha R
    J Med Virol; 2016 Jun; 88(6):923-30. PubMed ID: 26581026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
    Lo Presti A; Cella E; Angeletti S; Ciccozzi M
    Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
    Kumar M; Sudeep AB; Arankalle VA
    Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on Chikungunya pathophysiology in human and animal models.
    Couderc T; Lecuit M
    Microbes Infect; 2009 Dec; 11(14-15):1197-205. PubMed ID: 19737626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chikungunya virus arthritis in adult wild-type mice.
    Gardner J; Anraku I; Le TT; Larcher T; Major L; Roques P; Schroder WA; Higgs S; Suhrbier A
    J Virol; 2010 Aug; 84(16):8021-32. PubMed ID: 20519386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.